Executive Orders Aimed at Drug Costs Miss the Mark
Viewpoints from Craig Hasday Trying to regain momentum in the election polls, President Trump released four executive orders that he claims will “completely restructure” the prescription drug market. However, most analysts agree that there is not much new and nothing revolutionary in these orders. The most potentially impactful of these orders is a rehash from a prior Presidential Blueprint in May 2018. One order requires middlemen to pass along all discounts received to Medicare patients. Good idea, except for the provision that requires the Secretary of the Department of Health and Human Services (HHS) to confirm the order will not …
https://www.epicbrokers.com/insights/executive-orders-aimed-at-drug-costs-miss-the-mark/